Oocyte donation program using a simplified hormonal regimen.
It has been well recognized that both the synchronization of luteinizing hormone (LH) surge between the donor and the recipient for normally cycling women and the complex steroid replacement regimen given on a sequential and incremental basis for women with primary or secondary ovarian failure are two important aspects in oocyte donation. In oocyte donation program at SNUH, a simplified hormonal regimen applicable both to normally cycling women and to those with ovarian failure which consisted of administering 2 mg estradiol (E2) valerate orally 3 times a day augmented with 100 mg progesterone (P) in oil intramuscularly daily starting on the day preceding the oocyte retrieval from the donor was utilized. From July 1988 to December 1989 at SNUH, 11 cycles of oocyte donation program in 10 infertile patients were undertaken and 5 patients succeeded in pregnancy.
Chang
Y S
YS
Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Korea.
Kim
S H
SH
Choi
Y M
YM
Moon
S Y
SY
Lee
J Y
JY
D000328:Adult; D006063:Chorionic Gonadotropin / Q000097:blood / Q000627:therapeutic use; D004958:Estradiol / Q000031:analogs & derivatives / Q000097:blood / Q000627:therapeutic use; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D008596:Menotropins / Q000627:therapeutic use; D008597:Menstrual Cycle / Q000187:drug effects*; D008875:Middle Aged; D009865:Oocytes / Q000637:transplantation*; D010062:Ovulation Induction; D011247:Pregnancy / Q000378:metabolism; D011374:Progesterone / Q000097:blood / Q000627:therapeutic use
D006063:Chorionic Gonadotropin; D006728:Hormones; D011374:Progesterone; D004958:Estradiol; D008596:Menotropins; D005640:Follicle Stimulating Hormone